Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;42(3):361-371.
doi: 10.1007/s00774-024-01511-9. Epub 2024 May 20.

Sex-specific association of serum dehydroepiandrosterone and its sulfate levels with osteoporosis in type 2 diabetes

Shuo Li #  1 , Wei Li #  1 , Lina Chang #  1 , Jieying Wan  1 , Shanshan Chen  1 , Xinxin Zhang  2 , Qing He  3 , Ming Liu  4
Affiliations

Sex-specific association of serum dehydroepiandrosterone and its sulfate levels with osteoporosis in type 2 diabetes

Shuo Li et al. J Bone Miner Metab. 2024 May.

Abstract

Introduction: This study is to investigate the relation between serum dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) levels and the risk of osteoporosis in patients with T2DM.

Materials and methods: This cross-sectional study involved 938 hospitalized patients with T2DM. Linear regression models were used to explore the relationship between DHEA and DHEAS and the BMD at different skeletal sites. Multinominal logistic regression models and the restricted cubic spline (RCS) were used to evaluate the associations of DHEA and DHEAS with the risks of osteopenia and/or osteoporosis.

Results: In postmenopausal women with T2DM, after adjustment for confounders including testosterone and estradiol, DHEA showed a significant positive correlation with lumbar spine BMD (P = 0.013). Moreover, DHEAS exhibited significant positive correlations with BMD at three skeletal sites: including femoral neck, total hip, and lumbar spine (all P < 0.05). Low DHEA and DHEAS levels were associated with increased risk of osteopenia and/or osteoporosis (all P < 0.05) and the risk of osteoporosis gradually decreased with increasing DHEAS levels (P overall = 0.018, P-nonlinear = 0.559). However, DHEA and DHEAS levels in men over the age of 50 with T2DM were not associated with any of above outcomes.

Conclusion: In patients with T2DM, independent of testosterone and estradiol, higher DHEA and DHEAS levels are associated with higher BMD and lower risk of osteopenia/osteoporosis in postmenopausal women but not men over the age of 50.

Keywords: Bone mineral density; Dehydroepiandrosterone; Dehydroepiandrosterone sulfate; Osteoporosis; Type 2 diabetes.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Ward JL, Azzopardi PS, Francis KL et al (2021) Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the global burden of disease study 2019. The Lancet 398:1593–1618 - DOI
    1. Hofbauer LC, Busse B, Eastell R et al (2022) Bone fragility in diabetes: novel concepts and clinical implications. Lancet Diabetes Endocrinol 10:207–220 - PubMed - DOI
    1. Behanova M, Haschka J, Zwerina J et al (2021) The doubled burden of diabetic bone disease: hip fracture and post-hip fracture mortality. Eur J Endocrinol 184:627–636 - PubMed - DOI
    1. Kameda W, Daimon M, Oizumi T et al (2005) Association of decrease in serum dehydroepiandrosterone sulfate levels with the progression to type 2 diabetes in men of a Japanese population: the fungata study. Metabolism 54:669–676 - PubMed - DOI
    1. Brahimaj A, Muka T, Kavousi M et al (2017) Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: the rotterdam study. Diabetologia 60:98–106 - PubMed - DOI

LinkOut - more resources